A major trial finds the beta blocker bisoprolol neither improves nor worsens outcomes in people with COPD, despite the cardiovascular risk.
The National Institute for Health and Care Excellence (NICE), has published final draft guidance recommending dupilumab as a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results